St. Louis, May 14, 2018 – BacterioScan, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a 510(k) Premarket Notification clearance for its 216Dx Urinary Tract […]
Read MoreBioGenerator-backed AgTech Company Focuses on Naturally-Occurring Process ST. LOUIS – RNAgri, a St. Louis startup developing technology for agriculture, has entered a research collaboration with global agriculture company Monsanto. The […]
Read MoreBioGenerator-supported Company to Advance Cancer Therapies ST. LOUIS – St. Louis-based startup Unleash Immuno Oncolytics, which has developed viral-based biologics to attack cancerous tumors, has attracted a major investment from […]
Read MoreST. LOUIS – A panel of cardiologists, engineers, and other experts have given SentiAR, Inc.’s augmented reality (AR) platform an exceptional peer review, leading the National Institutes for Health (NIH) […]
Read MoreST. LOUIS – BioGenerator, the investment arm of BioSTL, has won a $300,000 grant from the U.S. Department of Commerce to capitalize on its retooled investment strategy. That strategy is […]
Read MoreBioGenerator supported startup company Disarm Therapeutics has closed a $30M financing led by top tier venture funds including Atlas Ventures. Prior to the company being formed, BioGenerator supported the academic […]
Read MoreSAN FRANCISCO — Cofactor Genomics, developer of a leading platform for RNA sequencing and expression analysis, today announced $18M in financing led by Menlo Ventures with major participation from existing […]
Read MoreST. LOUIS – SentiAR, Inc. has closed a $1.1M Seed Round to accelerate its work to revolutionize the operating room with augmented reality software designed to improve visualization in cardiac […]
Read MoreST. LOUIS –BioGenerator’s largest investment in any single company is paying off for St. Louis. Confluence Life Sciences, Inc. has been acquired by Aclaris Therapeutics, Inc. (NASDAQ: ACRS) for the […]
Read MorePrecision Virologics, a startup based on technology from Washington University, was created with support from BioGenerator Grants and BioSTL Fundamentals. BioGenerator Grant funding supported laboratory proof of concept, grant applications […]
Read More